Latest clinical trial results, FDA regulatory updates, and research guides.
Eli Lilly's triple agonist retatrutide achieved up to 28.7% average body weight loss in its first successful Phase 3 trial. Seven additional readouts expected throughout 2026. Here's everything researchers need to know.
RFK Jr. has signaled potential changes to the FDA's Category 2 peptide list — which currently bans BPC-157, TB-500, and 17 other compounds from compounding pharmacies. Here's the current regulatory landscape and what may change.
BPC-157 and TB-500 are the two most studied recovery peptides, often combined in research protocols. This guide breaks down their distinct mechanisms, overlapping effects, and what the latest research shows about each.
The GLP-1 class has expanded from a single compound to a multi-generational family of metabolic research tools. This guide covers every major compound — mechanism, half-life, research data, and what distinguishes each from the others.
The growth hormone secretagogue category includes GHRPs, GHRH analogues, and oral ghrelin mimetics — each with distinct receptor targets and GH release profiles. This research guide breaks down every major compound.
A new class of mitochondria-derived and telomere-targeted peptides is reshaping longevity research. This guide covers Epitalon, Humanin, MOTS-c, Foxo4-DRI, and what the research actually shows.
The cognitive peptide category ranges from well-characterized BDNF modulators to novel synaptogenic agents. This guide covers the mechanism and research profile of every major nootropic peptide available for laboratory study.
Proper reconstitution technique is critical for maintaining peptide integrity in research settings. This protocol guide covers bacteriostatic water selection, reconstitution steps, storage conditions, and common handling errors.
Eli Lilly's orforglipron — a non-peptide oral GLP-1 receptor agonist — has completed Phase 3 trials and is under FDA review with an action date in May 2026. Here's what the research shows and why it matters.
Not all peptide purity claims are equal. This guide explains what HPLC and mass spectrometry testing actually measure, how to read a Certificate of Analysis, and what to look for when evaluating a research peptide supplier.